Alex Pharma’s profits rise 3.8% YoY in FY 2021/2022
Updated 8/14/2022 12:04:00 PM
Arab Finance: Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) (AXPH) posted a 3.83% year-on-year (YoY) increase in net profit after tax fiscal year (FY) 2021/2022, according to financial indicators filed to the Egyptian Exchange (EGX) on August 14th.
Net profit after tax stood at EGP 121.479 million in the 12-month period ended June 30th, compared to EGP 116.996 million in FY 2020/2021.
The company’s revenue declined to EGP 1.087 billion in FY 2021/2022 from EGP 111.054 billion the fiscal year before.
Alex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary, and nutritional food products, as well as medical appliances.
